These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 15721090)

  • 1. Plasma levels of N-terminal pro-brain natriuretic peptide in patients with coronary artery disease and relation to clinical presentation, angiographic severity, and left ventricular ejection fraction.
    Ndrepepa G; Braun S; Mehilli J; von Beckerath N; Vogt W; Schömig A; Kastrati A
    Am J Cardiol; 2005 Mar; 95(5):553-7. PubMed ID: 15721090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.
    Kragelund C; Grønning B; Køber L; Hildebrandt P; Steffensen R
    N Engl J Med; 2005 Feb; 352(7):666-75. PubMed ID: 15716560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.
    Khan IA; Fink J; Nass C; Chen H; Christenson R; deFilippi CR
    Am J Cardiol; 2006 May; 97(10):1530-4. PubMed ID: 16679099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels.
    Hong SN; Ahn Y; Yoon NS; Lee KH; Kim YS; Hwang SH; Lee SR; Kim KH; Park HW; Hong YJ; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
    Am J Cardiol; 2007 Apr; 99(8):1051-4. PubMed ID: 17437726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-sensitivity troponin T level and angiographic severity of coronary artery disease.
    Ndrepepa G; Braun S; Schulz S; Mehilli J; Schömig A; Kastrati A
    Am J Cardiol; 2011 Sep; 108(5):639-43. PubMed ID: 21676369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between NT-pro BNP levels and early mitral annulus velocity (E') in patients with non-ST-segment elevation acute coronary syndrome.
    Barbosa MM; Nunes Mdo C; Castro LR; Nominato LF; Alencar MC; Ribeiro AL
    Echocardiography; 2008 Apr; 25(4):353-9. PubMed ID: 18177379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal pro-B-type natriuretic peptide: an independent marker for coronary artery disease in asymptomatic diabetic patients.
    Cosson E; Nguyen MT; Pham I; Pontet M; Nitenberg A; Valensi P
    Diabet Med; 2009 Sep; 26(9):872-9. PubMed ID: 19719707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of preprocedural N-terminal pro-brain natriuretic peptide in predicting angiographic no-reflow phenomenon during stent implantation in patients with ST-segment elevation acute myocardial infarction.
    Hong SN; Ahn Y; Hwang SH; Yoon NS; Lee SR; Moon JY; Kim KH; Hong YJ; Park HW; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
    Am J Cardiol; 2007 Aug; 100(4):631-4. PubMed ID: 17697819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of N-terminal pro-brain natriuretic peptide with the severity of coronary artery disease in patients with normal left ventricular ejection fraction.
    Wu N; Ma F; Guo Y; Li X; Liu J; Qing P; Xu R; Zhu C; Jia Y; Liu G; Dong Q; Jiang L; Li J
    Chin Med J (Engl); 2014; 127(4):627-32. PubMed ID: 24534213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between C-reactive protein levels and N-terminal pro-B-type natriuretic peptide in pre-dialysis patients.
    Ortega O; Gallar P; Muñoz M; Rodríguez I; Carreño A; Ortiz M; Molina A; Oliet A; Lozano L; Vigil A
    Nephron Clin Pract; 2004; 97(4):c125-30. PubMed ID: 15331941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment.
    Hunt PJ; Richards AM; Nicholls MG; Yandle TG; Doughty RN; Espiner EA
    Clin Endocrinol (Oxf); 1997 Sep; 47(3):287-96. PubMed ID: 9373449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited utilities of N-terminal pro B-type natriuretic peptide and other newer risk markers compared with traditional risk factors for prediction of significant angiographic lesions in stable coronary artery disease.
    Peer A; Falkensammer G; Alber H; Kroiss A; Griesmacher A; Ulmer H; Pachinger O; Mair J
    Heart; 2009 Feb; 95(4):297-303. PubMed ID: 18708421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study.
    Schnabel R; Rupprecht HJ; Lackner KJ; Lubos E; Bickel C; Meyer J; Münzel T; Cambien F; Tiret L; Blankenberg S;
    Eur Heart J; 2005 Feb; 26(3):241-9. PubMed ID: 15618051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Change in plasma N-terminal pro-brain natriuretic peptide in children with Kawasaki disease and its value in clinical practice].
    Zhang QY; Du JB; Chen YH; Li WZ
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):886-90. PubMed ID: 17254452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal pro-B-type natriuretic peptide as a diagnostic test for ventricular dysfunction in patients with coronary disease: data from the heart and soul study.
    Corteville DC; Bibbins-Domingo K; Wu AH; Ali S; Schiller NB; Whooley MA
    Arch Intern Med; 2007 Mar; 167(5):483-9. PubMed ID: 17353496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.
    Potocki M; Mair J; Weber M; Hamm C; Burkard T; Hiemetzberger R; Peters K; Jander N; Cron TA; Hess N; Hoffmann A; Gekeler H; Gohlke-Bärwolf C; Buser P; Mueller C
    Am J Cardiol; 2009 Aug; 104(4):559-64. PubMed ID: 19660612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-type natriuretic peptide as an independent predictor of coronary disease extension in non-ST elevation coronary syndromes with preserved systolic function.
    Palazzuoli A; Caputo M; Fineschi M; Navarri R; Calabrò A; Cameli M; Campagna MS; Franci B; Pierli C; Nuti R; Maisel A
    Eur J Prev Cardiol; 2012 Jun; 19(3):366-73. PubMed ID: 21464097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous coronary revascularization reduces plasma N-terminal pro-B-type natriuretic peptide concentration in stable coronary artery disease.
    McClure SJ; Gall S; Schechter CB; Kearney M; Zaman AG
    J Am Coll Cardiol; 2007 Jun; 49(25):2394-7. PubMed ID: 17599601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP secretion and extent of coronary artery stenosis in patients with stable coronary artery disease.
    Sakai H; Tsutamoto T; Ishikawa C; Tanaka T; Fujii M; Yamamoto T; Takashima H; Horie M
    Circ J; 2007 Apr; 71(4):499-505. PubMed ID: 17384449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.